Cargando…
Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
Background: Inflammation is known to promote tumor formation and progression; however, we found a natural anti-inflammatory factor, interleukin (IL)-1 receptor antagonist (IL1RN), in a mouse transgenic adenocarcinoma of the mouse prostate (TRAMP)-C1-derived tumor microenvironment (TME). We sought to...
Autores principales: | Fan, Yu-Ching, Lee, Kuan-Der, Tsai, Yuan-Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763916/ https://www.ncbi.nlm.nih.gov/pubmed/33322099 http://dx.doi.org/10.3390/biomedicines8120602 |
Ejemplares similares
-
Tumor-infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model
por: Fan, Yu-Ching, et al.
Publicado: (2020) -
Tumor-derived interleukin-1 receptor antagonist exhibits immunosuppressive functions and promotes pancreatic cancer
por: Fan, Yu-Ching, et al.
Publicado: (2023) -
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
por: Lindmark, F, et al.
Publicado: (2005) -
Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
por: Lewis, Anne M, et al.
Publicado: (2006) -
Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)